Cargando…
The blockade of T-cell co-stimulation as a therapeutic stratagem for immunosuppression: Focus on belatacept
The development of immunosuppressive drugs has in recent years been focused on prevention of acute rejection. This has led to an increase in one-year allograft survival. However, these drugs have non-immune effects which contribute to the high incidence of late graft loss, as a consequence of chroni...
Autores principales: | Snanoudj, Renaud, Frangié, Carlos, Deroure, Benjamin, François, Hélène, Créput, Caroline, Beaudreuil, Séverine, Dürrbach, Antoine, Charpentier, Bernard |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721321/ https://www.ncbi.nlm.nih.gov/pubmed/19707331 |
Ejemplares similares
-
Polyomavirus-Specific Cellular Immunity: From BK-Virus-Specific Cellular Immunity to BK-Virus-Associated Nephropathy?
por: Dekeyser, Manon, et al.
Publicado: (2015) -
Optimization of de novo belatacept‐based immunosuppression administered to renal transplant recipients
por: Kirk, Allan D., et al.
Publicado: (2020) -
Optimal management of primary focal segmental glomerulosclerosis in adults
por: Beaudreuil, Séverine, et al.
Publicado: (2017) -
Belatacept for Maintenance Immunosuppression in Lung Transplantation
por: Hui, Christine, et al.
Publicado: (2014) -
Renocardiac syndromes: physiopathology and treatment stratagems
por: Kingma, J. G., et al.
Publicado: (2015)